Correlation Between Scandion Oncology and Logistea A

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scandion Oncology and Logistea A at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scandion Oncology and Logistea A into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scandion Oncology AS and Logistea A, you can compare the effects of market volatilities on Scandion Oncology and Logistea A and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scandion Oncology with a short position of Logistea A. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scandion Oncology and Logistea A.

Diversification Opportunities for Scandion Oncology and Logistea A

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Scandion and Logistea is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Scandion Oncology AS and Logistea A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Logistea A and Scandion Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scandion Oncology AS are associated (or correlated) with Logistea A. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Logistea A has no effect on the direction of Scandion Oncology i.e., Scandion Oncology and Logistea A go up and down completely randomly.

Pair Corralation between Scandion Oncology and Logistea A

Assuming the 90 days trading horizon Scandion Oncology AS is expected to under-perform the Logistea A. In addition to that, Scandion Oncology is 3.91 times more volatile than Logistea A. It trades about -0.33 of its total potential returns per unit of risk. Logistea A is currently generating about -0.05 per unit of volatility. If you would invest  1,550  in Logistea A on August 31, 2024 and sell it today you would lose (35.00) from holding Logistea A or give up 2.26% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy95.65%
ValuesDaily Returns

Scandion Oncology AS  vs.  Logistea A

 Performance 
       Timeline  
Scandion Oncology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scandion Oncology AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Logistea A 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Logistea A has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Scandion Oncology and Logistea A Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scandion Oncology and Logistea A

The main advantage of trading using opposite Scandion Oncology and Logistea A positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scandion Oncology position performs unexpectedly, Logistea A can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Logistea A will offset losses from the drop in Logistea A's long position.
The idea behind Scandion Oncology AS and Logistea A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets